Fertility preservation in patients undergoing pelvic radiotherapy

Ribeiro, Daniela R.; Sá, Ana Cravo; Martins, Leonor Santos; Carolino, Elisabete; Borrego, Margarida

http://hdl.handle.net/10400.22/31109

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
POSTER_Ana Cravo Sá.pdf		66.71 KB	Adobe PDF	Download

Send Feedback

Authors

Ribeiro, Daniela R.

Sá, Ana Cravo

Martins, Leonor Santos

Carolino, Elisabete

Borrego, Margarida

Abstract(s)

Advances in oncology have led to increasingly earlier diagnosis and better survival rates (1). Combined with the current trend towards postponing parenthood, there will be more and more cancer survivors of childbearing age (2). The impact of pelvic radiotherapy on patients' fertility is making oncofertility an emerging clinical area. It is therefore essential that patients have the opportunity to discuss fertility preservation before treatment (3). This study aims (i) to assess whether the doses to the gonads of the 70 patients met the tolerance doses used in radiotherapy planning; (ii) to compare the 3DCRT with the VMAT techniques; (iii) to verify whether ovarian transposition reduces the dose to the ovaries.

Keywords

Fertility preservation Ovarian transposition

URI

http://hdl.handle.net/10400.22/31109

Citation

Ribeiro, D. R., Sá, A. C., Martins, L. S., Carolino, E., & Borrego, M. (2025). 3542 Fertility preservation in patients undergoing pelvic radiotherapy. ESTRO 2025 - Radiotherapy and Oncology, 206, S4190. https://doi.org/10.1016/S0167-8140(25)01786-4